Complications in alveolar ridge augmentation with special regard to patients receiving anticoagulant therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027945

Enrollment

150

Registered

2022-02-15

Start date

2017-11-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K08.2 Z92.1 Z92.2

Interventions

Group 1: Alveolar ridge augmentation in patients without anticoagulation or antiplatelet therapy Group 2: Alveolar ridge augmentation in patients with anticoagulation or antiplatelet therapy

Eligibility

Sex/Gender

All

Age

18 Years to 111 Years

Inclusion criteria

Inclusion criteria: Patients who have undergone jawbone augmentation as part of a planned implant placement.

Exclusion criteria

Exclusion criteria: Patients with a condition after malignant head and neck tumors, condition after radiation in the head and neck area, antiresorptive therapy (bisphosphonates, RANK-L inhibitors), previous orthognathic surgery.

Design outcomes

Primary

Measure	Time frame
Occurrence of a complication with a special evaluation of secondary bleeding, taking into account patient-related risk factors.	—

Secondary

Measure	Time frame
Success of the intervention in terms of a successful consecutive dental implant placement.	—

Countries

Germany

Contacts

Public ContactMichael Ermer

Uniklinik Freiburg Klinik für MKG Chirurgie

michael.ermer@uniklinik-freiburg.de076127047010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026